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The 2010s have seen a full recognition of the scourge of
antimicrobial resistance (AMR) where antibiotic-
resistance genes, many transferred from environmental
bacteria, spread rapidly through hospital and farm popu-
lations of pathogens when selected for by applied antibi-
otics. Many of these resistance traits allow survival of
bacteria in the very soil environments where other
organisms naturally produce antibiotics. In a hospital or
farm setting, they nullify the therapeutic effects of pre-
scribed antibiotics.
Along with this realization has come a return to natu-
ral environments to seek different new solutions.
Although these settings are both the source of genes
encoding the antibiotics we have relied upon and of the
resistance genes that circumvent individual antibiotic
agents or their actions, Nature offers much more than
just that. Diverse molecular tactics are employed,
between different micro-organisms, in natural environ-
ments, in a dazzling array of changing combinations to
gain advantage in conflicts for territory and food. The
war strategist in these processes is evolution and the
armies and vigilantes are bacteria, bacteriophage, proto-
zoa and fungi.
The iChip, a novel method for growing previously-
unculturable bacteria, in their natural environment,
developed by Kim Lewis and colleagues (Nichols et al.,
2010) has been used to access untapped environmental
bacteria for potential antibiotics (Ling et al., 2015).
Indeed this may lead to the next generation of antibiotics
that can be downstream processed into the pharmaceu-
ticals of tomorrow, and combined with better stewardship
may cause AMR to recede for future decades. In these
new antibiotic discovery approaches, we humans pick
up the individual weapons of micro-organisms, from their
battlefields, and fire them ourselves, against pathogens.
Certainly this will rearm humans to fight infection using
the principles first applied by Fleming, Florey and Chain.
Armed with advances in microscopy, 3rd generation
sequencing technologies and greater understanding of
the microbiota of different environments, we are now
able to ask, more holistically, how do whole micro-
organisms kill each other? From this fundamental knowl-
edge we will be able to employ them whole in the fight
against AMR infection. The advantage of this is that
multiple weapons may be used in a regulated way, by
whole micro-organisms, against their foes. This more
complex approach may be hard to resist by single gene
mutations in the pathogens. Elegant microscopic studies
by Melanie Blokesch and others (Borgeaud et al., 2015)
studying the Type VI secretion apparatus have shown
how environmental bacteria, such as Vibrio cholerae,
use that system to stab and poison adjacent bacteria in
a contact dependent manner wherein the killer senses
the ‘prey’.
The Type VI secretion apparatus shares conserved
structures with the injective machinery of the larger bac-
teriophage viruses of bacteria. Using phage allows a
multi-enzyme approach to bacterial killing but because a
single receptor is often the portal of phage attack, selec-
tion for phage-resistant mutants is possible. On the plus
side, given the enormous number and diversity of phage
on earth, cocktails of assorted phage can be useful to
delay the effect of such single genetic events (Merabish-
vili et al., 2009).
Another, but very different, whole organism approach
to bacterial killing, comes in the shape of predatory bac-
teria, including Bdellovibrio bacteriovorus. This invasive
predatory bacterium enters and kills a wide range of
Gram-negative bacteria and was, (akin to the discovery
of penicillin by Alexander Fleming), isolated in an envi-
ronmentally ‘infiltrated’ experiment that went unexpect-
edly. Stolp and Petzold isolated such predatory
Bdellovibrio from plaques on a bacterial lawn in an
experiment where they were studying phage. In fact,
miniature predatory soil bacteria, too small to cause
opacity were also able to invade and kill the larger bac-
teria on the lawn and produce plaques. (Stolp and Pet-
zold, 1962; Stolp and Starr, 1963).
Bacterial killing, by their predator ‘cousins’, does not
rely on receptor binding, and so does not select for
simple prey-resistance; but involves outer-membrane
contacts and Type IV pilus activity for prey-invasion.
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After this comes peptidoglycan modification, allowing
colonization of the prey periplasm; death of the invaded
bacterium and its consumption by waves of secreted
predator products. Recently, transcriptomics and trans-
poson mutagenesis studies of predatory bacteria have
shown the arsenal of some 200 bacterially destructive
enzymes that predators employ to kill prey and trans-
porters involved in their secretion or prey-derived nutri-
ent uptake (Medina et al., 2008; Tudor et al. 2008;
Lambert et al., 2010). This sometimes makes the Bdel-
lovibrio scientist think that using a single ‘molecular
weapon’ to combat pathogens might seem like a single
‘pop-gun’ compared to the ‘1812 Overture’ crescendo of
multiple enzymes that living predators employ to dis-
member their prey! As a study in 2011 showed that
Bdellovibrio are safe orally ingested by animals, the way
was open for more work using whole live predatory bac-
teria as anti-bacterials (Atterbury et al., 2011). Also the
observation by Iebba and colleagues (2013) that chil-
dren have DNA indicative of predatory bacteria in their
gut microbiota suggested that live predators, possibly
ingested accidentally in ‘a peck of muck’, (soil), during
play in the outdoor environment, may be not harmful in
the normal microbiota.
Encouraged by a US Government Defence Advanced
Research Projects Agency (DARPA) ‘Pathogen Preda-
tors Research Programme’, the vision of Dr. Barry Pal-
lotta and colleagues, researchers have taken, and
published, the next steps with therapeutic tests, using
whole live predatory bacteria. Shatzkes and colleagues
have shown that repeatedly-applied aerosols of predato-
ry Bdellovibrio restrict the bacterial burden of Klebsiella
pneumoniae in rat lungs (Shatzkes et al., 2016). Willis
and colleagues (2016) showed that injected Bdellovibrio
kill injected Shigella pathogens in the hindbrain of zebra-
fish embryos and that this treatment significantly
improves the survival of the zebrafish from c30% to 67%
at 72 h post infection. Moreover, the innate immune sys-
tem of the zebrafish synergises with the action of the
predators in clearing the pathogen (Willis et al., 2016).
Again this observation may relate back to complex
actions of protozoa and predatory bacteria in soil envi-
ronment. On the early earth, before evolution of higher
eukaryotes, simpler mechanisms of such eukaryotic–
prokaryotic cooperativity in soil may have contributed to
the evolution of the white blood cell (WBC)-predator
interactions seen in the zebrafish treatment experiments.
Although, as the zebrafish studies show, the immune
system will eventually clear live therapeutic predatory
bacteria, they may dwell in the bodily environment long
enough to be beneficial as an applied emergency dose
to an infected wound or surgery site (Willis et al., 2016).
Also the work of several laboratories shows that experi-
mental injection/ingestion/application of Bdellovibrio
alone to live animals or tissues, while causing some
inflammation, are not pathogenic (Atterbury et al., 2011;
Shatzkes et al., 2015; Gupta et al., 2016; Monnappa
et al., 2016; Willis et al., 2016).
These experiments make us think that natural live
predatory bacterial remedies may be beneficial treat-
ments for AMR infections, even though the idea of intro-
ducing more bacteria into an already pathogen-infected
host may sound unconventional.
The need for research into new antibacterial treatments
is great; a speech by John Rex MD, [at a meeting con-
vened by The Pew Charitable Trust, The Wellcome trust
and American Society for Microbiology, following publication
of The Pew Charitable Trusts report ‘A Scientific Roadmap
for Antibiotic Discovery’ (June 16, 2016)], put this into
sharp relief. John Rex suggested we think of antibiotics as
fire extinguishers (Rex and Outterson, 2016). Fire extin-
guishers are present in certified buildings and available at
all times. You may never have had to use one, but they are
always there. In the event of a fire, there’s no time to start
to build a fire service. In the same way anti-bacterials need
to be in reserve, ready and available in hospitals, even if
rarely used, except for new AMR infections. Scientific chal-
lenges need to be addressed now to ensure that the sup-
ply of such new anti-bacterials is there in advance of their
requirement as AMR infections increase.
We feel that whole predatory bacteria may be the con-
tents of future ‘extinguishers’, discharged into infected
compartments of the body to extinguish Gram-negative
infections, with bacteriophage additives to combat
Gram-positive co-infectors.
Predatory bacteria may not be suitable for systemic
blood stream infections; but they may play a role decolo-
nizing lungs, guts or wounds from problematic patho-
gens that resist conventional antibiotics. This approach
would bring with it a new challenges; production of
whole organisms rather than chemically defined drugs
for treatment will need to draw upon the food and brew-
ing industry as much as the pharmaceutical. Supporting
the patient’s physiology and immune status, during the
administration of the predators, and monitoring predator
clearance at the end of treatment will be vital.
Modern microscopic methods now make it more pos-
sible to follow and enumerate the predators in the new
environments of the living animal or human body. How
to assure the safety of a living predatory bacterium with
over 3,500 gene products, rather than a single chemical
entity like an antibiotic will be new and difficult legislative
– and safety – territory, but the advance of untreatable
AMR will certainly focus the minds of clinicians, scien-
tists, patients and legislators on relative risks. Further
animal studies will be very important and helpful. Indeed
test-treating farm livestock with predators for their con-
ventionally AMR infections and monitoring, (in contained
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conditions), the longevity and environmental fate of the
predators and pathogens (Ibrahim et al., 2016), as well
as the treatment outcome, will be a useful way ahead.
So in summary, although some of the genes encoding
AMR have come from soil bacteria, returning to Nature
to source solutions using the multi-faceted approaches
of live micro-organisms, including predatory bacteria, will
give new possibilities that take longer for pathogens to
resist. The natural properties of prokaryotic predators,
studied and applied by environmental as well as clinical
and fundamental microbiologists working together, can
bring new solutions to AMR.
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